Monocarboxylate Transporter 1 (MCTl) mediates the transport of the main fraction of lactate across the sarcolemma. A common polymorphic MCTl variant has been identified, but its role in high intensity exercise performance has not been defined. We investigated the influence of MCTl A1470T polymorphism (rsl049434) on lactate accumulation after high intensity circuit training. Ten men aged 20-26 performed three controlled circuit training (CWT) sessions at 60%, 70%, and 80% of the 15 repetition maximum (15 RM), in non-consecutive days. CWT included three sets of a circuit of eight exercises, obtaining lactate measurements immediately after each set had been completed. Two independent variables were analysed: MTC1 genotypes according to the presence or absence of the A1470T polymorphism, and the intensity of circuit training. Genotype distributions were in Hardy-Weinberg equilibrium, being 30% wild-type, 50% heterozygotes, and 20% mutated homozygotes. Mean lactate concentration at 80% of 15RM were significantly higher than the mean lactate values at the other intensities (p < 0.01). Significant differences between genetic groups were found in the lactate accumulation slope at 80% of 15 RM (p = 0.02) and in the maximal lactate concentration reached by all subjects in the study (L max ) (p = 0.03). The carriers of the A1470T polymorphism in the MTC1 gene seem to exhibit a worse lactate transport capability into the less active muscle cells for oxidation.
Introduction
Lactate transport across the sarcolemma is mainly mediated by proton-linked monocarboxylate transporters (MCTl and MCT4). [1] [2] [3] [4] In rats, there is a high correlation between
MCTl expression in muscle and the rate of blood lactate clearance. 5 ' 6 In humans, expression of MCTl may correlates with lactate removal 7 ' 8 and with the amount of lactate oxidised into muscle cells. 9 In humans, defects in MCTl transporter have been associated with several pathologies. Symptoms and signs of muscle injury on exercise and heat exposure plus subnormal erythrocyte lactate transport have been related with the presence of two mutations in the gene that codifies MCTl. An A1470T polymorphism (rs 1049434) in the MCTl gene (resulting in a glutamic acid to-aspartic acid change in codon 490), whose physiological role is still indeterminate, has been also reported. 10 Although there appear to be no clinical effects of this polymorphism, a 40% reduction of lactate transport rate has been identified in the erythrocytes of both individuals homozygous and heterozygous for this polymorphic variant. 10 In high-intensity exercise, anaerobic metabolism accounts for the subsequent lactic accumulation, 11 especially in resistance training, 12 ' 13 making it relevant to study this metabolite and its movement in the body during strength training. We performed a pilot study to investigate the influence of the A1470Tpolymorphism (rsl049434) MCTl genotypes on lactate accumulation after circuit training. We also examined whether the effect of this polymorphism on lactate accumulation depends on the intensity of the circuit training. We hypothesised that the A1470T gene polymorphism might lead to a reduction in the function of the MCT1 transporter, which would be reflected in a greater blood lactate accumulation.
Methods
Ten men (23.6 ±2.2 years; body mass: 78.2 ±7.0 kg; height: 179.2 ± 6.3 cm) gave their written informed consent to participate in this study, which was approved by the Human Research Review Ethics Committee of the School of Sport Sciences, Universidad Politécnica de Madrid. All had at least 1 year of experience in resistance training for 3-5 h per week, were between 20 and 30 years old, physically active and non-smokers. Individuals with diabetes, cardiovascular disease, or other metabolic disorders were excluded from the study.
Percentage body fat was estimated from six skinfolds 14 : triceps, subscapular, suprailium, abdominal, calf, and thigh. The following formula were applied: %Body fat = (((S6skinfolds) • 0.097) + 3.64) x 100 -1 Body mass and height were also measured.
14 Muscle mass (MM) was estimated using Martin's equation 15 :
• (forearm circumference) • 2 + 0.0331
The 15 repetition maximum (15 RM) for each exercise included in the circuit weight training (CWT) protocol was assessed twice on different days during the two wks prior to the CWT sessions, with an intra-class correlation coefficient of 0.870. The subjects came to the laboratory in non-consecutive days, assessing each day one of the following exercise groups: leg press and shoulder press; leg extensions, cable triceps extensions and lat pull-down; leg curl, biceps curl and seated chest press. A standardised warmup was performed for 10 min before each assessment, 16 and all the repetitions were performed at a pre-set rhythm of 1 s for the concentric phase and 2 s for the eccentric phase. The sounds of a pre-recorded CD ROM indicated this rhythm to the subjects. A movement specific warm-up was performed, with three sets of 15 repetitions (at 50%, 70%, and 90% of the estimated 15RM) with 2 min of recovery between the sets. After 5 min of recovery, a final set of 15 repetitions was carried at 100% of the estimated 15 RM. If the subject was able to perform more than 15 repetitions, another set was performed after 5 min, increasing the load of the 15RM of 2.5%. The load was lowered (-2.5% of 15 RM) if the subject could not perform 15 repetitions. A maximum of two attempts were performed in the same day. 17 During the tests, all the subjects were verbally encouraged in a standardised fashion to perform as many repetitions as possible. Participants came to the laboratory in three nonconsecutive days to undergo a CWT session at 60%, 70% or 80% of 15RM in a random order. Each session included three circuits of eight exercises (seated chest press, leg extensions, lat pull-down, leg press, shoulder press, leg curl, biceps curl, and cable triceps extensions), performing 15 repetitions in each exercise. Recoveries of 5 min between circuits and 10 s between exercises were set. Before each session, the subject performed a warm up circuit at 20% of their 15 RM. Throughout the session, the rhythm at which the exercises were performed was the same as the one used in the testing session, and given by the same CD ROM used in the preliminary session.
All of the subjects completed an initial adaptation phase, prior to all the testing. This involved the same CWT used in the testing sessions, performed three times per week during 4 weeks. All the exercises were performed on machines (Panatta, Italy). No free weights were used.
Capillary blood samples were obtained immediately after each circuit had been completed, and at minutes 3 and 5 after the end of the exercise bout. These samples were analysed by enzymatic method using the YSI1500 Sport Analyzer (YSI, Yellow Springs, OH, USA), obtaining the lactate concentrations immediately after the first (Lcl), the second (Lc2), and the third circuit (Lc3), and at minutes 3 and 5 after the end of the exercise bout. Calibrations before and after each session were carried according to manufacturer's recommendations.
Slopes of lactate accumulation (LA) throughout the sessions were obtained by individual linear regression equations. First, lactate values were plotted versus time of sampling for each subject and intensity. Then, a regression of the line obtained was performed, calculating its linear regression equation. Data of the nine subjects who completed the 60% and 70% sessions, and at least two circuits of the 80% session were included for this calculation.
To obtain the mean lactate concentration at each intensity (60%, 70% and 80%), lactate concentrations measured immediately after each of the three circuits were averaged (^average)-For every subject, the maximal lactate concentration reached throughout the whole study is reported (L max ), as well as the maximal lactate concentration reached at each intensity (L max Int).
Genomic DNA was extracted from peripheral blood using a QIAamp DNA Blood Mini kit (QIAGEN, Hilden, Germany). Genomic DNA from the subjects was analysed by polymerase chain reaction (PCR) amplification of a fragment containing the A1470T polymorphism of the MCT1 gene (rs 1049434, exon 5) and following direct sequencing. The primers used for amplification were as follows 10 : sense primer 5'-ACA CAT ACT GGG CAT GTG GC-3' (1455-1474); antisense primer 5'-AAA TCC CAT CAA TGA ACA ACT GGT ATG ATT TCC AC-3' (1807-1841). PCR reaction was made in a total volume of 50 (iL containing: 3 (xL genomic DNA, 1.5 mM MgC12,0.2 mM dNTP mix, 0.4 (xM primer, 4% dimethyl sulfoxide (SIGMA) and 1U Taq polymerase (BioTaq Polimerase, BioLine, London, UK). The amplification consisted of initial denaturation (94 °C, 5 min); 35 cycles consisting of denaturation (94 °C, 1 min), annealing (55 °C, 1 min), and extension (72 °C, 1 min); and final extension (72 °C, 10 min). PCR products were electrophoresed on 1.5% agarose gel to verify successful amplification of the 387 bp fragments. Prior to sequencing, the PCR products were purified using QIAquick PCR Purification Kit (QIA-GEN, Hilden, Germany). The sequencing reactions were carried out using dRhodamine Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA), and analysed on the automated ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). The nucleotide sequence of exon 5 was obtained from GeneBank (accession: NM_003051).
Subjects were allocated to two groups according to their profile of the MCTl gene. Subjects who presented the wild-type in their two alleles (AA) were allocated in the non-carriers group (NC), and the subjects who presented the A1470T polymorphism in at least one of their two alleles (AT or TT) were allocated in the carriers group (C).
Data are presented as mean ± standard deviation (SD). Chi-square analysis was used to test for Hardy-Weinberg equilibrium. Given the sample size and the variables distribution, non-parametric tests were used. Two independent variables were examined: MTC1 genotype according to the presence or absence of the A1470T polymorphism, and CWT intensities. Mann Whitney U tests were performed to analyse the differences between carrier (C) and non-carrier (NC) of the polymorphism for all the lactate variables at each intensity. The mean values for each intensity were compared using Friedman ANOVAs for repeated measures from the same subjects, followed by Wilcoxon test comparisons. An n of 10 in each group was adequate for a 0.05 alpha level and provide a statistical power of 0.80.
Results
The genotype distribution (30% wild-type, 50% heterozygotes, 20% mutated homozygotes) showed Hardy-Weinberg equilibrium. The allelic frequency was 0.55 and 0.45 for the wild-type allele and for the polymorphic allele, respectively.
The carriers were 24.1 ±1.3 year old, had a body mass of 81.2 ± 6.7 kg, and were 180.2 ± 5.1 cm tall. The non-carriers were 23.7 ±3.2 year old, had a body mass of 71.2 ±2.5 kg, and were 173.6 ±4.2 cm tall. There were no differences in the various anthropometric variables, except for body mass (p = 0.03).
The mean lactate concentration at 80% was significantly higher that the mean values at the other intensities (p < 0.01) ( Table 1) .
The Mann-Whitney test showed significant differences in the LA slope at 80% of 15 RM between the carriers and non- Values are means ± SD. Lc 1, lactate concentration immediately after the first lap. Lc2, lactate concentration immediately after the second lap. Lc3, lactate concentration immediately after the third lap. La Vera ge, average of Lcl, Lc2 and Lc3. Lmaxlnt, maximal lactate concentration observed at each intensity.
Significant differences with the other intensities, p < 0.01.
carriers (p = 0.02). Fig. 1 shows the values for the LA slopes at the three exercise intensities. The test also detected significant differences for L max (p = 0.03). L max occurred after the last circuit at the highest intensity they could complete (70% or 80% of 15 RM) in all but two subjects. One of them reached it after the last 60% CWT, and the other at minute 3 after the end of the 80% CWT. The values of the main lactate variables for both genetic groups are shown in Table 2 .
Discussion
We found significant differences between genetic groups in the LA slope produced during the 80% CWT, and also in the highest lactate concentration value reached during the study.
Merezhinskaya et al. first described the A1470T polymorphism of MCTl in patients with deficiency of lactate transport. 10 There was no clinical relevance of the polymor- Values are means ± SD. C, carriers group (heterozygotes plus mutated homozygotes). NC, non-carriers group (homozygotes wild-type), ¿average» average of the lactate concentrations immediately after each lap. Lmaxlnt, maximal lactate concentration observed at each intensity, ¿max, maximal lactate concentration observed in the whole study.
Significant differences between genetic groups, p = 0.03.
phism, but erythrocyte lactate transport rates were 60-65% of normal. We documented a significant difference in the lactate accumulation in subjects undergoing maximal effort performing high intensity circuit training. Previous investigations in humans have shown that MCT expression is upregulated after physical training. Endurance, 18 24 or increase several days after the exercise bout. 7 We have considered this confounding factor selecting our cohort from individuals with similar training experience, and including an identical initial adaptation phase for all the subjects.
One of the missense mutations described by Merezhinskaya et al. (A>T at coding base 1470) was found in 40 healthy volunteers, and this polymorphism probably had no clinical effect on lactate transport. 10 In our study, we found this polymorphism in healthy individuals, with an allelic frequency of 0.45.
The main differences in the interpretation of Merezhinskaya et al. 10 observations and ours concern the different ways used to assess the MCTl function as lactate transporter. They measured erythrocyte lactate transporter in vitro, and also with an analytic forearm test, the lactate ammonia exercise ratio (LAER) test, modified from the clinical ischemic forearm test. In the LAER test, the blood flow through the exercising arm is controlled to permit diffusion equilibrium between blood and muscle lactate. Despite this control of blood flow, the test and the in vitro assay do not reproduce the conditions occurring during intense physical exercise, where the less active muscles use the lactate as fuel and the muscle lactate transporters (MCTl and MCT4) operate together. 25 We used high intensity CWT to produce high lactate concentrations. We expected that the lactate concentration slope would not have been influenced by the training status of our subjects or by their muscle mass, as opposed to absolute values of lactate concentration. The higher concentrations observed in carriers at the end of the CWT session and the higher L max could be caused by impaired functionality in MCTl which would lead to impaired lactate transport into the less active muscle cells for oxidation, thus increasing blood lactate concentration. 4 ' 5 This could increase muscle fatigue, given the results of previous studies showing a negative correlation between MCTl content and fatigue indices. 8 The change in the transporter also could increase the risk of suffering similar symptoms as those presented in MCTl mutations carriers, 10 especially in conditions such as very intensity training. In our study, the differences between the MCTl groups occur only at the highest intensity. Trying to explain this lack of difference at lower intensities, we suggest a lactate concentration threshold necessary to observe differences between the groups. Under this threshold, the polymorphic transporter could cover the required lactate movement, but, if the production lactate increases disproportionately, the ability of the modified transporter would be insufficient.
To our knowledge, this is the first study investigating the potential influence of MCTl A1470T polymorphism during progressively more intense exercise. Potential confounders could be the different diet of the subjects, which can influence substrate utilization and thus lactate production, [26] [27] [28] the relatively small, though statistically appropriate, sample size, the different percentages of muscle fibers among the subjects, which determine MCTl expression, 23 or the fact that we measured blood lactate instead of muscle lactate concentration.
In conclusion, carriers for MCTl A1470T polymorphism showed higher lactate accumulations than non-carriers during high intensity CWT. Although this observation should be considered with caution given our small sample size, these results should be taken into account in future studies relating MCTl expression and lactate transport within exercise. 23 Further research is also required to investigate the implications of this genetic factor in acid-base balance during exercise, and whether these influences are also present in women.
Practical implications
• Carriers of the MCT1 A1470T polymorphism have higher lactate accumulation than noncarriers during high intensity CWT.
• This difference in lactate accumulation manifests at high intensity exercise.
• High intensity resistance training loads could be titrated according to the genetic makeup of individual athletes.
